Overview

Nasal Naloxone for Narcotic Overdose

Status:
Unknown status
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine if nasal naloxone is inferior to standard care for naloxone administration in a pre-hospital setting. Ambulance squads in Adams, Clermont, and Scioto counties in southern Ohio will be randomized to provide either standard care or nasal (IN) naloxone as the initial response to a suspected opioid overdose. Standard care includes administration of naloxone by intravenous (IV), intramuscular (IM) or intraosseus (IO) methods.
Phase:
Phase 4
Details
Lead Sponsor:
Judith Feinberg
Treatments:
Naloxone
Narcotics